These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 19409827)

  • 21. Chronic refractory idiopathic thrombocytopenic purpura (ITP) and anti-CD20 monoclonal antibody: a case report.
    Latifzadeh SZ; Entezari V
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):489-92. PubMed ID: 17000895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of chronic immune thrombocytopenic purpura in children and adults.
    Blanchette V; Freedman J; Garvey B
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):36-51. PubMed ID: 9523748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency.
    Carbone J; Escudero A; Mayayo M; Ballesteros M; Perez-Corral A; Sanchez-Ramon S; Sarmiento E; Micheloud D; Fernandez-Cruz E
    Ann N Y Acad Sci; 2005 Jun; 1051():666-71. PubMed ID: 16127007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence of treatments for adults with primary immune thrombocytopenia.
    George JN
    Am J Hematol; 2012 May; 87 Suppl 1():S12-5. PubMed ID: 22389032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splenectomy for treatment of immune thrombocytopenic purpura.
    Malcovati L; Della Porta MG
    Haematologica; 2005 Jan; 90(1):4. PubMed ID: 15644305
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of idiopathic thrombocytopenic purpura in adults].
    Godeau B; Bierling P
    Presse Med; 2008 Sep; 37(9):1292-8. PubMed ID: 18644317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reassessment of treatment modalities for paediatric patients with chronic immune thrombocytopenia.
    Laws HJ; Janssen G; Borkhardt A
    Hamostaseologie; 2009 May; 29(2):171-6. PubMed ID: 19404521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of prednisone and splenectomy in patients with idiopathic thrombocytopenic purpura: only splenectomy induces a complete remission.
    Louwes H; Vellenga E; Houwerzijl EJ; de Wolf JT
    Ann Hematol; 2001 Dec; 80(12):728-32. PubMed ID: 11797113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic idiopathic thrombocytopenic purpura: mechanisms of pathogenesis.
    Gernsheimer T
    Oncologist; 2009 Jan; 14(1):12-21. PubMed ID: 19144680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C; Reu FJ; Ho AD; Hensel M
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
    Gernsheimer TB
    Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The future expected therapeutic approaches for ITP patients].
    Kurata Y
    Nihon Rinsho; 2003 Apr; 61(4):664-9. PubMed ID: 12718093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of an infant with severe acute refractory immune thrombocytopenic purpura using combination therapy including rituximab.
    Iesato K; Hatakeyama N; Yamamoto M; Hori T; Inazawa N; Tsutsumi H; Suzuki N
    Pediatr Blood Cancer; 2009 Aug; 53(2):203-5. PubMed ID: 19301247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe chronic idiopathic thrombocytopenic purpura during childhood: definition, management, and prognosis.
    Buchanan GR; Journeycake JM; Adix L
    Semin Thromb Hemost; 2003 Dec; 29(6):595-603. PubMed ID: 14719176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial management of adults with idiopathic (immune) thrombocytopenic purpura.
    George JN
    Blood Rev; 2002 Mar; 16(1):37-8. PubMed ID: 11913992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Management of idiopathic thrombocytopenic purpura (primary immune thrombocytopenia, ITP)].
    Kashiwagi H; Tomiyama Y
    Rinsho Ketsueki; 2014 Oct; 55(10):2087-94. PubMed ID: 25297775
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of immune thrombocytopenic purpura in adults.
    Stasi R; Provan D
    Mayo Clin Proc; 2004 Apr; 79(4):504-22. PubMed ID: 15065616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel approaches to refractory immune thrombocytopenic purpura.
    Bussel JB
    Blood Rev; 2002 Mar; 16(1):31-6. PubMed ID: 11913991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment.
    Dickerhoff R; von Ruecker A
    J Pediatr; 2000 Nov; 137(5):629-32. PubMed ID: 11060527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis and therapy of idiopathic thrombocytopenic purpura (ITP) in adults].
    Chrobák L
    Vnitr Lek; 2002 Aug; 48(8):773-80. PubMed ID: 12425210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.